

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 8.48623615 |
| 2 | muscle filament sliding (GO:0030049) | 8.48623615 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.49489294 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.49489294 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.05741328 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 6.96375287 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.92128663 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 6.92128663 |
| 9 | actin-mediated cell contraction (GO:0070252) | 6.85268270 |
| 10 | skeletal muscle contraction (GO:0003009) | 6.74765737 |
| 11 | fatty acid elongation (GO:0030497) | 6.19061522 |
| 12 | axon ensheathment in central nervous system (GO:0032291) | 5.92793362 |
| 13 | central nervous system myelination (GO:0022010) | 5.92793362 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 5.77869625 |
| 15 | response to muscle activity (GO:0014850) | 5.00836457 |
| 16 | glyoxylate metabolic process (GO:0046487) | 4.95817696 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.88302512 |
| 18 | striated muscle contraction (GO:0006941) | 4.84178580 |
| 19 | NADH metabolic process (GO:0006734) | 4.82730495 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.81753040 |
| 21 | regulation of relaxation of muscle (GO:1901077) | 4.81186755 |
| 22 | * creatine metabolic process (GO:0006600) | 4.79413034 |
| 23 | actin filament-based movement (GO:0030048) | 4.78801624 |
| 24 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.78293963 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.78174772 |
| 26 | cysteine metabolic process (GO:0006534) | 4.72252461 |
| 27 | skeletal muscle fiber development (GO:0048741) | 4.71291573 |
| 28 | myofibril assembly (GO:0030239) | 4.59958916 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 4.53304361 |
| 30 | cholesterol biosynthetic process (GO:0006695) | 4.46316386 |
| 31 | gluconeogenesis (GO:0006094) | 4.42969735 |
| 32 | glycogen catabolic process (GO:0005980) | 4.37031055 |
| 33 | sarcomere organization (GO:0045214) | 4.31452331 |
| 34 | myotube cell development (GO:0014904) | 4.26707518 |
| 35 | tryptophan catabolic process (GO:0006569) | 4.26062778 |
| 36 | indole-containing compound catabolic process (GO:0042436) | 4.26062778 |
| 37 | indolalkylamine catabolic process (GO:0046218) | 4.26062778 |
| 38 | very long-chain fatty acid metabolic process (GO:0000038) | 4.23020177 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 4.22499643 |
| 40 | coenzyme catabolic process (GO:0009109) | 4.21295739 |
| 41 | 2-oxoglutarate metabolic process (GO:0006103) | 4.19963355 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 4.18003270 |
| 43 | oxaloacetate metabolic process (GO:0006107) | 4.17261443 |
| 44 | bile acid metabolic process (GO:0008206) | 4.15375511 |
| 45 | fructose metabolic process (GO:0006000) | 4.13158035 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.12909308 |
| 47 | heme transport (GO:0015886) | 4.12568859 |
| 48 | exogenous drug catabolic process (GO:0042738) | 4.12167540 |
| 49 | sulfur amino acid catabolic process (GO:0000098) | 4.11873943 |
| 50 | kynurenine metabolic process (GO:0070189) | 4.11649132 |
| 51 | regulation of fibrinolysis (GO:0051917) | 4.11597979 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.08224138 |
| 53 | hexose biosynthetic process (GO:0019319) | 4.07983906 |
| 54 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.07263993 |
| 55 | protein carboxylation (GO:0018214) | 4.06327391 |
| 56 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.06327391 |
| 57 | tryptophan metabolic process (GO:0006568) | 4.05294565 |
| 58 | intestinal cholesterol absorption (GO:0030299) | 3.99614931 |
| 59 | glucan catabolic process (GO:0009251) | 3.98434957 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 3.93313965 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 3.92490773 |
| 62 | serine family amino acid biosynthetic process (GO:0009070) | 3.90959312 |
| 63 | sterol biosynthetic process (GO:0016126) | 3.89921470 |
| 64 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.86647468 |
| 65 | cofactor catabolic process (GO:0051187) | 3.85058367 |
| 66 | regulation of cholesterol esterification (GO:0010872) | 3.84015565 |
| 67 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.82689635 |
| 68 | glucan biosynthetic process (GO:0009250) | 3.81392087 |
| 69 | glycogen biosynthetic process (GO:0005978) | 3.81392087 |
| 70 | L-serine metabolic process (GO:0006563) | 3.78091646 |
| 71 | drug catabolic process (GO:0042737) | 3.77897385 |
| 72 | aldehyde catabolic process (GO:0046185) | 3.76854887 |
| 73 | axon ensheathment (GO:0008366) | 3.76462881 |
| 74 | ensheathment of neurons (GO:0007272) | 3.76462881 |
| 75 | alpha-amino acid catabolic process (GO:1901606) | 3.73694891 |
| 76 | myelination (GO:0042552) | 3.73584753 |
| 77 | monosaccharide biosynthetic process (GO:0046364) | 3.72154923 |
| 78 | cellular polysaccharide catabolic process (GO:0044247) | 3.71185883 |
| 79 | short-chain fatty acid metabolic process (GO:0046459) | 3.70321420 |
| 80 | acetyl-CoA metabolic process (GO:0006084) | 3.70135824 |
| 81 | * muscle contraction (GO:0006936) | 3.68487113 |
| 82 | urea metabolic process (GO:0019627) | 3.66357796 |
| 83 | urea cycle (GO:0000050) | 3.66357796 |
| 84 | regulation of triglyceride catabolic process (GO:0010896) | 3.66265519 |
| 85 | complement activation, alternative pathway (GO:0006957) | 3.65782833 |
| 86 | reverse cholesterol transport (GO:0043691) | 3.62716852 |
| 87 | nitrogen cycle metabolic process (GO:0071941) | 3.61473547 |
| 88 | regulation of protein activation cascade (GO:2000257) | 3.61469253 |
| 89 | tricarboxylic acid cycle (GO:0006099) | 3.61279974 |
| 90 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.59348062 |
| 91 | ethanol oxidation (GO:0006069) | 3.56617983 |
| 92 | plasma lipoprotein particle remodeling (GO:0034369) | 3.55295361 |
| 93 | protein-lipid complex remodeling (GO:0034368) | 3.55295361 |
| 94 | macromolecular complex remodeling (GO:0034367) | 3.55295361 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.54636037 |
| 96 | cardiac myofibril assembly (GO:0055003) | 3.54317801 |
| 97 | ubiquinone biosynthetic process (GO:0006744) | 3.54249963 |
| 98 | cholesterol efflux (GO:0033344) | 3.53371339 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 3.52990304 |
| 100 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.52254984 |
| 101 | serine family amino acid catabolic process (GO:0009071) | 3.50630899 |
| 102 | aspartate family amino acid catabolic process (GO:0009068) | 3.48714905 |
| 103 | triglyceride homeostasis (GO:0070328) | 3.47682649 |
| 104 | acylglycerol homeostasis (GO:0055090) | 3.47682649 |
| 105 | response to inactivity (GO:0014854) | 3.47248334 |
| 106 | cardiac muscle contraction (GO:0060048) | 3.47008301 |
| 107 | response to mercury ion (GO:0046689) | 3.46001990 |
| 108 | acyl-CoA biosynthetic process (GO:0071616) | 3.44967575 |
| 109 | thioester biosynthetic process (GO:0035384) | 3.44967575 |
| 110 | quinone biosynthetic process (GO:1901663) | 3.44018772 |
| 111 | ketone body metabolic process (GO:1902224) | 3.43990436 |
| 112 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.43815217 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.42555473 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.42555473 |
| 115 | homocysteine metabolic process (GO:0050667) | 3.42170249 |
| 116 | thioester metabolic process (GO:0035383) | 3.39865349 |
| 117 | acyl-CoA metabolic process (GO:0006637) | 3.39865349 |
| 118 | glutamate metabolic process (GO:0006536) | 3.38740106 |
| 119 | opsonization (GO:0008228) | 3.36842365 |
| 120 | cholesterol metabolic process (GO:0008203) | 3.35325479 |
| 121 | regulation of complement activation (GO:0030449) | 3.33628330 |
| 122 | cellular biogenic amine catabolic process (GO:0042402) | 3.32360252 |
| 123 | amine catabolic process (GO:0009310) | 3.32360252 |
| 124 | oxidative phosphorylation (GO:0006119) | 3.30579990 |
| 125 | negative regulation of sterol transport (GO:0032372) | 3.29541999 |
| 126 | negative regulation of cholesterol transport (GO:0032375) | 3.29541999 |
| 127 | muscle fiber development (GO:0048747) | 3.28379484 |
| 128 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.28308396 |
| 129 | cellular modified amino acid catabolic process (GO:0042219) | 3.28123186 |
| 130 | polysaccharide catabolic process (GO:0000272) | 3.27324400 |
| 131 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.26120400 |
| 132 | * muscle system process (GO:0003012) | 3.25849608 |
| 133 | muscle cell fate commitment (GO:0042693) | 3.24277699 |
| 134 | cholesterol homeostasis (GO:0042632) | 3.23101565 |
| 135 | actomyosin structure organization (GO:0031032) | 3.21299465 |
| 136 | response to methylmercury (GO:0051597) | 3.20776938 |
| 137 | phospholipid efflux (GO:0033700) | 3.20091351 |
| 138 | fibrinolysis (GO:0042730) | 3.19787156 |
| 139 | glycine metabolic process (GO:0006544) | 3.19151319 |
| 140 | skeletal muscle adaptation (GO:0043501) | 3.18374232 |
| 141 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.18240324 |
| 142 | epoxygenase P450 pathway (GO:0019373) | 3.18140833 |
| 143 | blood coagulation, intrinsic pathway (GO:0007597) | 3.17625055 |
| 144 | sterol homeostasis (GO:0055092) | 3.15428696 |
| 145 | carboxylic acid catabolic process (GO:0046395) | 3.15294438 |
| 146 | organic acid catabolic process (GO:0016054) | 3.15294438 |
| 147 | iron coordination entity transport (GO:1901678) | 3.14639824 |
| 148 | cellular glucuronidation (GO:0052695) | 3.13866009 |
| 149 | sterol metabolic process (GO:0016125) | 3.13808864 |
| 150 | regulation of cholesterol metabolic process (GO:0090181) | 3.13529184 |
| 151 | muscle organ morphogenesis (GO:0048644) | 3.12446906 |
| 152 | negative regulation of lipase activity (GO:0060192) | 3.11941855 |
| 153 | plasma membrane repair (GO:0001778) | 3.11019002 |
| 154 | ubiquinone metabolic process (GO:0006743) | 3.10345663 |
| 155 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.09841012 |
| 156 | muscle cell cellular homeostasis (GO:0046716) | 3.09350764 |
| 157 | regulation of plasminogen activation (GO:0010755) | 3.06840763 |
| 158 | glycogen metabolic process (GO:0005977) | 3.05006833 |
| 159 | regulation of actin filament-based movement (GO:1903115) | 3.04087509 |
| 160 | regulation of glucokinase activity (GO:0033131) | 3.00755271 |
| 161 | regulation of hexokinase activity (GO:1903299) | 3.00755271 |
| 162 | amino-acid betaine metabolic process (GO:0006577) | 2.98223251 |
| 163 | regulation of cell communication by electrical coupling (GO:0010649) | 2.97444029 |
| 164 | glucan metabolic process (GO:0044042) | 2.94985139 |
| 165 | cellular glucan metabolic process (GO:0006073) | 2.94985139 |
| 166 | oxidative demethylation (GO:0070989) | 2.93583727 |
| 167 | omega-hydroxylase P450 pathway (GO:0097267) | 2.92443019 |
| 168 | branched-chain amino acid catabolic process (GO:0009083) | 2.92300050 |
| 169 | skeletal muscle tissue development (GO:0007519) | 2.91293453 |
| 170 | L-methionine biosynthetic process (GO:0071265) | 2.84403726 |
| 171 | amino acid salvage (GO:0043102) | 2.84403726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.53829406 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.87498559 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.91150407 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.84717514 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.84650104 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.90043810 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.59473505 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.14151612 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.12187505 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.94334384 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.71733125 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50763452 |
| 13 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.38386078 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.37220218 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.32595298 |
| 16 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20454727 |
| 17 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.09614503 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.07339469 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.07186558 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.05625011 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.95675960 |
| 22 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.93158950 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.91120474 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87640115 |
| 25 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.86102923 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80279338 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.78309805 |
| 28 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.76742890 |
| 29 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.76644295 |
| 30 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.73999690 |
| 31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.70069297 |
| 32 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.68295242 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67185613 |
| 34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.63355898 |
| 35 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.63170952 |
| 36 | * P68_20966046_ChIP-Seq_HELA_Human | 1.61682228 |
| 37 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59272640 |
| 38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.58186025 |
| 39 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.52795928 |
| 40 | SA1_27219007_Chip-Seq_Bcells_Human | 1.44095474 |
| 41 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42715489 |
| 42 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.42306060 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36385973 |
| 44 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.32816992 |
| 45 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.28980582 |
| 46 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28659458 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.28241254 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.27084340 |
| 49 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.26418037 |
| 50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24725771 |
| 51 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.24564876 |
| 52 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.24418039 |
| 53 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.24389768 |
| 54 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.23309178 |
| 55 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.22972220 |
| 56 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22785072 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22448631 |
| 58 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.22440445 |
| 59 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22362779 |
| 60 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20969428 |
| 61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19337452 |
| 62 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.18637944 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18125306 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18125306 |
| 65 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.18010098 |
| 66 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.17843054 |
| 67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17067641 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16977959 |
| 69 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.16269961 |
| 70 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.15821014 |
| 71 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15149303 |
| 72 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13978627 |
| 73 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.13512878 |
| 74 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.13512878 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12200631 |
| 76 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.11830842 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11557864 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11356030 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11136634 |
| 80 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.10970829 |
| 81 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.10762907 |
| 82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10321230 |
| 83 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.10025213 |
| 84 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.09546062 |
| 85 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.09530266 |
| 86 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.09000656 |
| 87 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08717412 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05054412 |
| 89 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.04567324 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04294399 |
| 91 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04017065 |
| 92 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.03651707 |
| 93 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02623723 |
| 94 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.02567105 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02403089 |
| 96 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.02267673 |
| 97 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.02187849 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01259564 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01002534 |
| 100 | * RAC3_21632823_ChIP-Seq_H3396_Human | 1.00740083 |
| 101 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00282886 |
| 102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99501740 |
| 103 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.99371494 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97967122 |
| 105 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.97104839 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96304145 |
| 107 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94689481 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94109432 |
| 109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93699899 |
| 110 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.91365187 |
| 111 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.91353419 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90650849 |
| 113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90058708 |
| 114 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89133719 |
| 115 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.88799586 |
| 116 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87764638 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87479375 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85680923 |
| 119 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83499593 |
| 120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82924197 |
| 121 | CBP_21632823_ChIP-Seq_H3396_Human | 0.82818746 |
| 122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82786303 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82663023 |
| 124 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.82552074 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82256082 |
| 126 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80551333 |
| 127 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.79977215 |
| 128 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.79572461 |
| 129 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.78745712 |
| 130 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.78645875 |
| 131 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.78406690 |
| 132 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78104516 |
| 133 | NCOR_22424771_ChIP-Seq_293T_Human | 0.75778049 |
| 134 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.74128209 |
| 135 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.74104709 |
| 136 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72526775 |
| 137 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.72170066 |
| 138 | VDR_22108803_ChIP-Seq_LS180_Human | 0.71820982 |
| 139 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.71710709 |
| 140 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.71106392 |
| 141 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.70613297 |
| 142 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.70597715 |
| 143 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.70220362 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70187432 |
| 145 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.70043570 |
| 146 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.69758900 |
| 147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68499680 |
| 148 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.68457461 |
| 149 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.67744711 |
| 150 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.67744711 |
| 151 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67265888 |
| 152 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.67248480 |
| 153 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.66891887 |
| 154 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.66504188 |
| 155 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.66255986 |
| 156 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.65908993 |
| 157 | GATA1_19941826_ChIP-Seq_K562_Human | 0.65480195 |
| 158 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65298176 |
| 159 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.65236582 |
| 160 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.65104490 |
| 161 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.64955350 |
| 162 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.64955350 |
| 163 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.64121847 |
| 164 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.64097186 |
| 165 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.63735788 |
| 166 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.63545157 |
| 167 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.63515521 |
| 168 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.63385578 |
| 169 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63308550 |
| 170 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.62814503 |
| 171 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.62664565 |
| 172 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.62631606 |
| 173 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.61867985 |
| 174 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.61592588 |
| 175 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.61456658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.61112856 |
| 2 | MP0003646_muscle_fatigue | 5.95088713 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 5.93355909 |
| 4 | MP0005360_urolithiasis | 5.91982863 |
| 5 | MP0005365_abnormal_bile_salt | 5.30669001 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 5.28074992 |
| 7 | MP0000751_myopathy | 5.26909060 |
| 8 | MP0000749_muscle_degeneration | 5.00348782 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 4.76281081 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 4.21352114 |
| 11 | MP0005083_abnormal_biliary_tract | 3.93088558 |
| 12 | MP0004036_abnormal_muscle_relaxation | 3.63981408 |
| 13 | MP0002106_abnormal_muscle_physiology | 3.25631747 |
| 14 | MP0001666_abnormal_nutrient_absorption | 3.19278895 |
| 15 | MP0000920_abnormal_myelination | 3.18971934 |
| 16 | MP0003195_calcinosis | 3.15036718 |
| 17 | MP0000759_abnormal_skeletal_muscle | 3.00620711 |
| 18 | MP0009840_abnormal_foam_cell | 3.00003273 |
| 19 | MP0004087_abnormal_muscle_fiber | 2.86627461 |
| 20 | MP0002269_muscular_atrophy | 2.77348537 |
| 21 | MP0005369_muscle_phenotype | 2.74661323 |
| 22 | MP0003252_abnormal_bile_duct | 2.70412735 |
| 23 | MP0004233_abnormal_muscle_weight | 2.66600568 |
| 24 | MP0005330_cardiomyopathy | 2.65426997 |
| 25 | MP0010329_abnormal_lipoprotein_level | 2.57111934 |
| 26 | MP0002332_abnormal_exercise_endurance | 2.52638140 |
| 27 | * MP0005332_abnormal_amino_acid | 2.41811660 |
| 28 | MP0000750_abnormal_muscle_regeneration | 2.40540579 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 2.38310111 |
| 30 | MP0004084_abnormal_cardiac_muscle | 2.26605403 |
| 31 | MP0003690_abnormal_glial_cell | 2.24506654 |
| 32 | MP0004130_abnormal_muscle_cell | 2.23952746 |
| 33 | MP0005620_abnormal_muscle_contractility | 2.23830417 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 2.09241789 |
| 35 | MP0003329_amyloid_beta_deposits | 2.00628364 |
| 36 | MP0003868_abnormal_feces_composition | 1.98128195 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.71581450 |
| 38 | MP0005670_abnormal_white_adipose | 1.71202327 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.69092746 |
| 40 | MP0002972_abnormal_cardiac_muscle | 1.69015641 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.67471890 |
| 42 | MP0000604_amyloidosis | 1.66014427 |
| 43 | MP0000733_abnormal_muscle_development | 1.62928126 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52050549 |
| 45 | MP0002108_abnormal_muscle_morphology | 1.48918107 |
| 46 | MP0000609_abnormal_liver_physiology | 1.48214168 |
| 47 | MP0005408_hypopigmentation | 1.45364626 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.36619369 |
| 49 | MP0001661_extended_life_span | 1.35079820 |
| 50 | MP0003011_delayed_dark_adaptation | 1.33397887 |
| 51 | MP0004019_abnormal_vitamin_homeostasis | 1.33032562 |
| 52 | MP0004215_abnormal_myocardial_fiber | 1.30557609 |
| 53 | MP0003186_abnormal_redox_activity | 1.28592257 |
| 54 | MP0000003_abnormal_adipose_tissue | 1.24686051 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.20117013 |
| 56 | MP0004142_abnormal_muscle_tone | 1.19097030 |
| 57 | MP0002822_catalepsy | 1.18140673 |
| 58 | MP0001764_abnormal_homeostasis | 1.17222638 |
| 59 | MP0010630_abnormal_cardiac_muscle | 1.16472029 |
| 60 | MP0004885_abnormal_endolymph | 1.16332780 |
| 61 | MP0004381_abnormal_hair_follicle | 1.12330097 |
| 62 | MP0001529_abnormal_vocalization | 1.11541523 |
| 63 | MP0009697_abnormal_copulation | 1.09837088 |
| 64 | MP0005220_abnormal_exocrine_pancreas | 1.08789446 |
| 65 | MP0001905_abnormal_dopamine_level | 1.08664957 |
| 66 | MP0004270_analgesia | 1.08270525 |
| 67 | MP0003634_abnormal_glial_cell | 1.07568947 |
| 68 | MP0003137_abnormal_impulse_conducting | 1.05102028 |
| 69 | MP0002127_abnormal_cardiovascular_syste | 1.04015559 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 1.03294814 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.01483360 |
| 72 | MP0003632_abnormal_nervous_system | 1.01471758 |
| 73 | MP0000372_irregular_coat_pigmentation | 0.98752120 |
| 74 | MP0002229_neurodegeneration | 0.98634171 |
| 75 | MP0005385_cardiovascular_system_phenoty | 0.97515382 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 0.97515382 |
| 77 | MP0005375_adipose_tissue_phenotype | 0.96597123 |
| 78 | MP0004484_altered_response_of | 0.95323713 |
| 79 | MP0010030_abnormal_orbit_morphology | 0.93487449 |
| 80 | MP0005058_abnormal_lysosome_morphology | 0.93334324 |
| 81 | MP0003879_abnormal_hair_cell | 0.91442966 |
| 82 | MP0006138_congestive_heart_failure | 0.89517986 |
| 83 | * MP0009643_abnormal_urine_homeostasis | 0.88786653 |
| 84 | MP0004043_abnormal_pH_regulation | 0.87989897 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.87832851 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.86728212 |
| 87 | MP0003880_abnormal_central_pattern | 0.85376387 |
| 88 | MP0005647_abnormal_sex_gland | 0.85013048 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.84819688 |
| 90 | MP0004147_increased_porphyrin_level | 0.84724644 |
| 91 | MP0005410_abnormal_fertilization | 0.83279279 |
| 92 | MP0006035_abnormal_mitochondrial_morpho | 0.81543303 |
| 93 | MP0000462_abnormal_digestive_system | 0.80887268 |
| 94 | MP0004510_myositis | 0.80776469 |
| 95 | MP0002272_abnormal_nervous_system | 0.79535455 |
| 96 | MP0004742_abnormal_vestibular_system | 0.79173874 |
| 97 | MP0009763_increased_sensitivity_to | 0.77796351 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.76491904 |
| 99 | MP0002234_abnormal_pharynx_morphology | 0.74899261 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.73793029 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.73527076 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.73330619 |
| 103 | MP0000598_abnormal_liver_morphology | 0.71885964 |
| 104 | MP0002295_abnormal_pulmonary_circulatio | 0.71508678 |
| 105 | MP0001346_abnormal_lacrimal_gland | 0.70073126 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.69171032 |
| 107 | MP0000747_muscle_weakness | 0.68219245 |
| 108 | MP0006082_CNS_inflammation | 0.68125820 |
| 109 | MP0003631_nervous_system_phenotype | 0.68019060 |
| 110 | MP0001486_abnormal_startle_reflex | 0.67716179 |
| 111 | MP0009780_abnormal_chondrocyte_physiolo | 0.67431603 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66386447 |
| 113 | MP0003136_yellow_coat_color | 0.65714937 |
| 114 | MP0008260_abnormal_autophagy | 0.65156859 |
| 115 | * MP0006036_abnormal_mitochondrial_physio | 0.64602799 |
| 116 | MP0002249_abnormal_larynx_morphology | 0.64414292 |
| 117 | MP0010678_abnormal_skin_adnexa | 0.63733059 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.62931232 |
| 119 | MP0005535_abnormal_body_temperature | 0.62426749 |
| 120 | * MP0005451_abnormal_body_composition | 0.61996205 |
| 121 | MP0000647_abnormal_sebaceous_gland | 0.58859438 |
| 122 | MP0005171_absent_coat_pigmentation | 0.58518318 |
| 123 | * MP0009642_abnormal_blood_homeostasis | 0.57916555 |
| 124 | MP0002064_seizures | 0.57341861 |
| 125 | MP0002090_abnormal_vision | 0.57187075 |
| 126 | MP0004085_abnormal_heartbeat | 0.56420168 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.54879386 |
| 128 | MP0003633_abnormal_nervous_system | 0.54875687 |
| 129 | MP0000778_abnormal_nervous_system | 0.54644187 |
| 130 | MP0000579_abnormal_nail_morphology | 0.54597960 |
| 131 | MP0008469_abnormal_protein_level | 0.53813041 |
| 132 | MP0002971_abnormal_brown_adipose | 0.53595369 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.52357130 |
| 134 | MP0005645_abnormal_hypothalamus_physiol | 0.51882279 |
| 135 | MP0008874_decreased_physiological_sensi | 0.51676513 |
| 136 | MP0000383_abnormal_hair_follicle | 0.51256926 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.50887455 |
| 138 | MP0008872_abnormal_physiological_respon | 0.50834424 |
| 139 | MP0005448_abnormal_energy_balance | 0.48735492 |
| 140 | MP0005195_abnormal_posterior_eye | 0.48087455 |
| 141 | MP0003718_maternal_effect | 0.47570945 |
| 142 | * MP0005452_abnormal_adipose_tissue | 0.47509926 |
| 143 | MP0005266_abnormal_metabolism | 0.46322011 |
| 144 | MP0002876_abnormal_thyroid_physiology | 0.46156853 |
| 145 | MP0003638_abnormal_response/metabolism_ | 0.45057491 |
| 146 | MP0005334_abnormal_fat_pad | 0.44547367 |
| 147 | MP0005187_abnormal_penis_morphology | 0.42808775 |
| 148 | MP0000230_abnormal_systemic_arterial | 0.42607107 |
| 149 | MP0000955_abnormal_spinal_cord | 0.42527488 |
| 150 | MP0000566_synostosis | 0.42273470 |
| 151 | MP0003075_altered_response_to | 0.41487226 |
| 152 | MP0008873_increased_physiological_sensi | 0.41220288 |
| 153 | MP0004134_abnormal_chest_morphology | 0.39660116 |
| 154 | MP0006276_abnormal_autonomic_nervous | 0.35919576 |
| 155 | MP0000266_abnormal_heart_morphology | 0.35451184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.44808650 |
| 2 | Nemaline bodies (HP:0003798) | 9.41585520 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.09692477 |
| 4 | Exercise-induced myalgia (HP:0003738) | 7.45505194 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 6.94169106 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.85952034 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 6.70790395 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 6.13381155 |
| 9 | Deep venous thrombosis (HP:0002625) | 5.82996987 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.46936039 |
| 11 | Distal arthrogryposis (HP:0005684) | 5.42805008 |
| 12 | Myopathic facies (HP:0002058) | 5.40346989 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.98072128 |
| 14 | Xanthomatosis (HP:0000991) | 4.94506513 |
| 15 | Rhabdomyolysis (HP:0003201) | 4.90827633 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.90802632 |
| 17 | Calf muscle hypertrophy (HP:0008981) | 4.83428496 |
| 18 | Myoglobinuria (HP:0002913) | 4.75291674 |
| 19 | Round ear (HP:0100830) | 4.67522395 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.67081577 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 4.66151513 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 4.60766867 |
| 23 | Ulnar deviation of the wrist (HP:0003049) | 4.16650774 |
| 24 | Neurofibrillary tangles (HP:0002185) | 4.12905177 |
| 25 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.06901110 |
| 26 | Fat malabsorption (HP:0002630) | 3.95193321 |
| 27 | Abnormality of the calf musculature (HP:0001430) | 3.88251086 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.86717393 |
| 29 | Calcaneovalgus deformity (HP:0001848) | 3.78178026 |
| 30 | Hyporeflexia of lower limbs (HP:0002600) | 3.73049428 |
| 31 | Muscle fiber splitting (HP:0003555) | 3.72944653 |
| 32 | Rimmed vacuoles (HP:0003805) | 3.66459221 |
| 33 | Neck muscle weakness (HP:0000467) | 3.64650687 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.64503001 |
| 35 | Muscle stiffness (HP:0003552) | 3.62323084 |
| 36 | Steatorrhea (HP:0002570) | 3.59861784 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.56830881 |
| 38 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.55716235 |
| 39 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.55716235 |
| 40 | Complement deficiency (HP:0004431) | 3.47460496 |
| 41 | Hyperammonemia (HP:0001987) | 3.47211853 |
| 42 | Subaortic stenosis (HP:0001682) | 3.45978128 |
| 43 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.45978128 |
| 44 | Hyperglycinemia (HP:0002154) | 3.45367899 |
| 45 | Ketosis (HP:0001946) | 3.44488790 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 3.40550345 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.40550345 |
| 48 | Deformed tarsal bones (HP:0008119) | 3.36303297 |
| 49 | Absent phalangeal crease (HP:0006109) | 3.33347258 |
| 50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.29555846 |
| 51 | Hypolipoproteinemia (HP:0010981) | 3.28701113 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.23855530 |
| 53 | Epidermoid cyst (HP:0200040) | 3.23588903 |
| 54 | Parakeratosis (HP:0001036) | 3.22316006 |
| 55 | Sensory axonal neuropathy (HP:0003390) | 3.21318497 |
| 56 | Joint hemorrhage (HP:0005261) | 3.20895420 |
| 57 | Abnormality of glycolysis (HP:0004366) | 3.11857249 |
| 58 | Increased serum pyruvate (HP:0003542) | 3.11857249 |
| 59 | Abnormality of the common coagulation pathway (HP:0010990) | 3.11822911 |
| 60 | Asymmetric septal hypertrophy (HP:0001670) | 3.03892543 |
| 61 | Myotonia (HP:0002486) | 3.03878148 |
| 62 | Cerebral inclusion bodies (HP:0100314) | 3.01411050 |
| 63 | Conjugated hyperbilirubinemia (HP:0002908) | 3.01306124 |
| 64 | Increased variability in muscle fiber diameter (HP:0003557) | 2.97367281 |
| 65 | Increased connective tissue (HP:0009025) | 2.94714003 |
| 66 | Malignant hyperthermia (HP:0002047) | 2.94077368 |
| 67 | Spastic paraparesis (HP:0002313) | 2.93117185 |
| 68 | Distal lower limb muscle weakness (HP:0009053) | 2.89907077 |
| 69 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.81310315 |
| 70 | Areflexia of lower limbs (HP:0002522) | 2.77840393 |
| 71 | Abnormality of the corticospinal tract (HP:0002492) | 2.77586887 |
| 72 | Cerebral edema (HP:0002181) | 2.76993705 |
| 73 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.73562957 |
| 74 | Hyperglycinuria (HP:0003108) | 2.73098220 |
| 75 | Sudden death (HP:0001699) | 2.71921673 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 2.70088705 |
| 77 | Abnormality of the intrinsic pathway (HP:0010989) | 2.68720869 |
| 78 | Abnormal finger flexion creases (HP:0006143) | 2.67314724 |
| 79 | Difficulty running (HP:0009046) | 2.66462724 |
| 80 | Progressive muscle weakness (HP:0003323) | 2.65588180 |
| 81 | Frequent falls (HP:0002359) | 2.64926548 |
| 82 | Hypoglycemic coma (HP:0001325) | 2.58908106 |
| 83 | Amyloidosis (HP:0011034) | 2.55055801 |
| 84 | Exercise intolerance (HP:0003546) | 2.54959884 |
| 85 | Hypercholesterolemia (HP:0003124) | 2.53874715 |
| 86 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51435999 |
| 87 | Cerebral hemorrhage (HP:0001342) | 2.51430435 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49262602 |
| 89 | Abnormality of serum amino acid levels (HP:0003112) | 2.49175206 |
| 90 | Hyperbilirubinemia (HP:0002904) | 2.45541327 |
| 91 | Delayed CNS myelination (HP:0002188) | 2.45443347 |
| 92 | Hypophosphatemic rickets (HP:0004912) | 2.43638107 |
| 93 | EMG: neuropathic changes (HP:0003445) | 2.41148200 |
| 94 | Lethargy (HP:0001254) | 2.40335672 |
| 95 | Increased muscle lipid content (HP:0009058) | 2.37168112 |
| 96 | Fetal akinesia sequence (HP:0001989) | 2.36493748 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 2.35909712 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35909712 |
| 99 | Vascular calcification (HP:0004934) | 2.35874138 |
| 100 | Cholecystitis (HP:0001082) | 2.35333227 |
| 101 | Abnormal gallbladder physiology (HP:0012438) | 2.35333227 |
| 102 | Bulbar palsy (HP:0001283) | 2.34987861 |
| 103 | Ragged-red muscle fibers (HP:0003200) | 2.31550285 |
| 104 | Generalized muscle weakness (HP:0003324) | 2.31442730 |
| 105 | Abnormal gallbladder morphology (HP:0012437) | 2.29318920 |
| 106 | Abnormality of complement system (HP:0005339) | 2.29101372 |
| 107 | Acute encephalopathy (HP:0006846) | 2.27199164 |
| 108 | Ketoacidosis (HP:0001993) | 2.27188650 |
| 109 | Leukodystrophy (HP:0002415) | 2.26332329 |
| 110 | Bundle branch block (HP:0011710) | 2.26242814 |
| 111 | Metabolic acidosis (HP:0001942) | 2.25948733 |
| 112 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.22099465 |
| 113 | Limb-girdle muscle atrophy (HP:0003797) | 2.21325199 |
| 114 | Paraparesis (HP:0002385) | 2.20850542 |
| 115 | Dilated cardiomyopathy (HP:0001644) | 2.20631137 |
| 116 | Opisthotonus (HP:0002179) | 2.19096427 |
| 117 | Brushfield spots (HP:0001088) | 2.18038467 |
| 118 | Hepatocellular necrosis (HP:0001404) | 2.17916916 |
| 119 | Methylmalonic acidemia (HP:0002912) | 2.17235609 |
| 120 | Acute necrotizing encephalopathy (HP:0006965) | 2.16944731 |
| 121 | Weak cry (HP:0001612) | 2.14361690 |
| 122 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11998481 |
| 123 | Intention tremor (HP:0002080) | 2.10855342 |
| 124 | Gowers sign (HP:0003391) | 2.09941818 |
| 125 | Onion bulb formation (HP:0003383) | 2.09481844 |
| 126 | Axonal loss (HP:0003447) | 2.09477015 |
| 127 | Abnormality of the calcaneus (HP:0008364) | 2.07003766 |
| 128 | Irritability (HP:0000737) | 2.05706312 |
| 129 | Cardiovascular calcification (HP:0011915) | 2.05578283 |
| 130 | Mitochondrial inheritance (HP:0001427) | 2.03584014 |
| 131 | Cholelithiasis (HP:0001081) | 2.02535000 |
| 132 | Ventricular tachycardia (HP:0004756) | 2.02489430 |
| 133 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.00145302 |
| 134 | Rickets (HP:0002748) | 1.99914348 |
| 135 | Spastic gait (HP:0002064) | 1.99819362 |
| 136 | Heart block (HP:0012722) | 1.97840746 |
| 137 | Slender build (HP:0001533) | 1.97620131 |
| 138 | Vomiting (HP:0002013) | 1.96364790 |
| 139 | Acanthocytosis (HP:0001927) | 1.95780842 |
| 140 | Spontaneous abortion (HP:0005268) | 1.94849533 |
| 141 | Abnormality of vitamin metabolism (HP:0100508) | 1.92905928 |
| 142 | Scapular winging (HP:0003691) | 1.92827774 |
| 143 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.91272142 |
| 144 | Renal Fanconi syndrome (HP:0001994) | 1.91144355 |
| 145 | Abnormal atrioventricular conduction (HP:0005150) | 1.89240509 |
| 146 | 3-Methylglutaconic aciduria (HP:0003535) | 1.88663342 |
| 147 | Autoamputation (HP:0001218) | 1.87222651 |
| 148 | Cerebral hypomyelination (HP:0006808) | 1.86558511 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.86169998 |
| 150 | Abnormality of the Achilles tendon (HP:0005109) | 1.85832754 |
| 151 | Cerebral palsy (HP:0100021) | 1.85283096 |
| 152 | Skin nodule (HP:0200036) | 1.84941832 |
| 153 | Pancreatitis (HP:0001733) | 1.84901427 |
| 154 | Methylmalonic aciduria (HP:0012120) | 1.84318823 |
| 155 | Abnormality of the neuromuscular junction (HP:0003398) | 1.83150978 |
| 156 | Fatigable weakness (HP:0003473) | 1.83150978 |
| 157 | Glycosuria (HP:0003076) | 1.81824420 |
| 158 | Abnormality of urine glucose concentration (HP:0011016) | 1.81824420 |
| 159 | Hepatic necrosis (HP:0002605) | 1.81303716 |
| 160 | Slow saccadic eye movements (HP:0000514) | 1.81117915 |
| 161 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.80482222 |
| 162 | Increased CSF lactate (HP:0002490) | 1.79996309 |
| 163 | Stridor (HP:0010307) | 1.79889758 |
| 164 | Muscle fiber atrophy (HP:0100295) | 1.79771449 |
| 165 | Delayed myelination (HP:0012448) | 1.79757145 |
| 166 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.78398565 |
| 167 | Spinal rigidity (HP:0003306) | 1.78296589 |
| 168 | Type 2 muscle fiber atrophy (HP:0003554) | 1.77662133 |
| 169 | Lactic acidosis (HP:0003128) | 1.77362878 |
| 170 | Difficulty climbing stairs (HP:0003551) | 1.76788395 |
| 171 | Peripheral hypomyelination (HP:0007182) | 1.76366430 |
| 172 | Spastic tetraparesis (HP:0001285) | 1.75405289 |
| 173 | Hepatosplenomegaly (HP:0001433) | 1.75307961 |
| 174 | Myocardial infarction (HP:0001658) | 1.75138630 |
| 175 | Hemorrhage of the eye (HP:0011885) | 1.74550771 |
| 176 | Abnormality of the gallbladder (HP:0005264) | 1.74534913 |
| 177 | Lipoatrophy (HP:0100578) | 1.74264219 |
| 178 | Progressive macrocephaly (HP:0004481) | 1.73701684 |
| 179 | Waddling gait (HP:0002515) | 1.73509899 |
| 180 | Gout (HP:0001997) | 1.72908060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.16003436 |
| 2 | PHKG1 | 5.82359728 |
| 3 | PHKG2 | 5.82359728 |
| 4 | TTN | 4.96368799 |
| 5 | OXSR1 | 4.28069243 |
| 6 | BCKDK | 4.21480853 |
| 7 | EPHB1 | 3.60206802 |
| 8 | BCR | 2.92467870 |
| 9 | PBK | 2.74638376 |
| 10 | PKN1 | 2.58875172 |
| 11 | MET | 2.57102281 |
| 12 | WNK4 | 2.50684700 |
| 13 | VRK2 | 2.40309561 |
| 14 | FGFR2 | 2.21221497 |
| 15 | CSNK1G3 | 2.15310472 |
| 16 | CDK19 | 2.03554126 |
| 17 | CSNK1A1L | 2.02335424 |
| 18 | ICK | 1.97614231 |
| 19 | MUSK | 1.84837262 |
| 20 | CSNK1G1 | 1.75302811 |
| 21 | MAPKAPK3 | 1.75290130 |
| 22 | LIMK1 | 1.71497760 |
| 23 | ERBB4 | 1.64442033 |
| 24 | NME1 | 1.62351678 |
| 25 | MAP2K3 | 1.59979558 |
| 26 | CSNK1G2 | 1.59352852 |
| 27 | MAP3K11 | 1.53047595 |
| 28 | MAPKAPK5 | 1.49255307 |
| 29 | CCNB1 | 1.46536037 |
| 30 | PRPF4B | 1.46486762 |
| 31 | WNK1 | 1.45525518 |
| 32 | TNIK | 1.43217530 |
| 33 | NME2 | 1.42560426 |
| 34 | SIK1 | 1.39936458 |
| 35 | NTRK1 | 1.38103363 |
| 36 | NEK6 | 1.37577215 |
| 37 | CAMK2B | 1.31924031 |
| 38 | NEK1 | 1.30021310 |
| 39 | MAPK15 | 1.28755283 |
| 40 | CAMK2G | 1.26289313 |
| 41 | FGFR4 | 1.22919475 |
| 42 | PIM2 | 1.16046157 |
| 43 | TESK2 | 1.15563378 |
| 44 | ROCK2 | 1.15427200 |
| 45 | CAMK2D | 1.15306386 |
| 46 | EEF2K | 1.12731308 |
| 47 | MAP2K6 | 1.09117022 |
| 48 | TRIB3 | 1.07528544 |
| 49 | UHMK1 | 1.07404863 |
| 50 | INSRR | 1.07047600 |
| 51 | MAP2K2 | 1.02013748 |
| 52 | EPHA4 | 1.00772032 |
| 53 | PDK2 | 0.99827499 |
| 54 | SGK494 | 0.98358281 |
| 55 | SGK223 | 0.98358281 |
| 56 | PRKCQ | 0.98109097 |
| 57 | ERN1 | 0.97702061 |
| 58 | PAK6 | 0.97543368 |
| 59 | PIK3CG | 0.96975398 |
| 60 | FGR | 0.96845621 |
| 61 | AKT2 | 0.92583425 |
| 62 | DYRK1B | 0.91820594 |
| 63 | MAPK11 | 0.91319824 |
| 64 | MARK1 | 0.89728718 |
| 65 | ABL2 | 0.88321669 |
| 66 | DYRK2 | 0.88124062 |
| 67 | PDPK1 | 0.82631456 |
| 68 | PAK3 | 0.81553494 |
| 69 | MST4 | 0.79601269 |
| 70 | TESK1 | 0.77977763 |
| 71 | PRKAA1 | 0.76066013 |
| 72 | OBSCN | 0.73273932 |
| 73 | TAOK2 | 0.72793043 |
| 74 | ARAF | 0.70309681 |
| 75 | CLK1 | 0.69605941 |
| 76 | IRAK2 | 0.68594266 |
| 77 | CAMK2A | 0.67966644 |
| 78 | PRKD3 | 0.67464110 |
| 79 | PRKD1 | 0.66953928 |
| 80 | MST1R | 0.66624326 |
| 81 | TYRO3 | 0.66189595 |
| 82 | KDR | 0.64830227 |
| 83 | TAOK3 | 0.64136950 |
| 84 | PNCK | 0.60197349 |
| 85 | GSK3A | 0.59931863 |
| 86 | CDK14 | 0.58987843 |
| 87 | SCYL2 | 0.58850416 |
| 88 | MOS | 0.55676831 |
| 89 | PIK3CA | 0.54156871 |
| 90 | PRKCZ | 0.53279056 |
| 91 | CAMK4 | 0.53073783 |
| 92 | IRAK3 | 0.52758148 |
| 93 | PINK1 | 0.50674665 |
| 94 | SMG1 | 0.49448245 |
| 95 | CSK | 0.48961700 |
| 96 | MAPK7 | 0.48519654 |
| 97 | PRKACB | 0.47131713 |
| 98 | CDK15 | 0.46277051 |
| 99 | VRK1 | 0.45713786 |
| 100 | PRKG1 | 0.45537808 |
| 101 | MARK2 | 0.45430993 |
| 102 | TRPM7 | 0.44947627 |
| 103 | FYN | 0.44898300 |
| 104 | TLK1 | 0.44151460 |
| 105 | CDK5 | 0.42747692 |
| 106 | IRAK1 | 0.42561442 |
| 107 | CSNK1D | 0.42177714 |
| 108 | PAK2 | 0.42044579 |
| 109 | PRKCE | 0.41326728 |
| 110 | CDK8 | 0.41061207 |
| 111 | DAPK1 | 0.40835070 |
| 112 | MAP3K13 | 0.40491489 |
| 113 | MAP2K4 | 0.40374641 |
| 114 | BRAF | 0.40357414 |
| 115 | GRK1 | 0.40201950 |
| 116 | CDK18 | 0.39359518 |
| 117 | CDK11A | 0.38656489 |
| 118 | DAPK3 | 0.37305752 |
| 119 | CAMK1 | 0.37213769 |
| 120 | BMPR1B | 0.36159460 |
| 121 | ITK | 0.35915585 |
| 122 | STK16 | 0.35882655 |
| 123 | DAPK2 | 0.35748046 |
| 124 | PDK1 | 0.35296970 |
| 125 | CSNK1A1 | 0.35228493 |
| 126 | MAPK12 | 0.34918587 |
| 127 | PRKAA2 | 0.34360233 |
| 128 | MAP2K7 | 0.34288238 |
| 129 | MAP3K1 | 0.33506669 |
| 130 | MAPK13 | 0.32155801 |
| 131 | TBK1 | 0.32033284 |
| 132 | KSR2 | 0.31795025 |
| 133 | RPS6KA5 | 0.31760113 |
| 134 | PRKACA | 0.31713394 |
| 135 | PRKCH | 0.31613148 |
| 136 | PRKACG | 0.30925697 |
| 137 | CASK | 0.29080510 |
| 138 | AURKA | 0.28816163 |
| 139 | ILK | 0.28438419 |
| 140 | MAPK4 | 0.28309966 |
| 141 | NEK9 | 0.27878115 |
| 142 | ERBB2 | 0.26821298 |
| 143 | ERBB3 | 0.26671825 |
| 144 | ABL1 | 0.26117817 |
| 145 | MAP3K7 | 0.25973614 |
| 146 | MAP2K1 | 0.25470151 |
| 147 | ROCK1 | 0.24869699 |
| 148 | RAF1 | 0.23781262 |
| 149 | RPS6KA3 | 0.20800993 |
| 150 | TNK2 | 0.20519776 |
| 151 | RPS6KB2 | 0.19978686 |
| 152 | GRK5 | 0.19426695 |
| 153 | RPS6KB1 | 0.17248666 |
| 154 | MAP4K2 | 0.17177868 |
| 155 | CSNK2A2 | 0.16727952 |
| 156 | ZAK | 0.16515819 |
| 157 | DMPK | 0.15682741 |
| 158 | LRRK2 | 0.15178151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.66751095 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.26824179 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.19655628 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.97688031 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.93994727 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.88040753 |
| 7 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.69984664 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.55571582 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52830006 |
| 10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.52690534 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38942887 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.32049487 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25587125 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.17647488 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15448204 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.10170405 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.09648206 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08535851 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07731904 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03332109 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01667599 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.98549370 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86822084 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84353798 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82394677 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81082417 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.63401232 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.61572482 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59217004 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57145489 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50166000 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47740979 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47642808 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46938861 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42645507 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41805187 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41514848 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.37611712 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37259166 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25951635 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24462312 |
| 42 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.23004516 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21637861 |
| 44 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19048174 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15259725 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12324644 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12295551 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.10776823 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05658922 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04888913 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.02515622 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99955658 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97500117 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96206242 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95877191 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94802379 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94156944 |
| 58 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.93883191 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92762622 |
| 60 | Protein export_Homo sapiens_hsa03060 | 0.91678310 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.91120722 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90654892 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89647015 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88247724 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88176205 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.87163142 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85827331 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84087510 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81493450 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78971967 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73436372 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73238175 |
| 73 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.64649026 |
| 74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64325099 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63700517 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.63082739 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.58122483 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55075085 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54759830 |
| 80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51928664 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49604227 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46208958 |
| 83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44043997 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43329394 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.40843943 |
| 86 | Base excision repair_Homo sapiens_hsa03410 | 0.39396149 |
| 87 | RNA polymerase_Homo sapiens_hsa03020 | 0.38033925 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37064831 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36934579 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35445932 |
| 91 | Proteasome_Homo sapiens_hsa03050 | 0.33470230 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33391230 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33062341 |
| 94 | Ribosome_Homo sapiens_hsa03010 | 0.32127819 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.31551062 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.28172985 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27712508 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24408645 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.22331452 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22262743 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.21586665 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.16574611 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14643350 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14579289 |
| 105 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.12207632 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | 0.12020390 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11019215 |
| 108 | Huntingtons disease_Homo sapiens_hsa05016 | 0.09965178 |
| 109 | DNA replication_Homo sapiens_hsa03030 | 0.06786377 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.06006950 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.04641570 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.03021721 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | -0.1050896 |
| 114 | Tight junction_Homo sapiens_hsa04530 | -0.0927703 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | -0.0912259 |
| 116 | Malaria_Homo sapiens_hsa05144 | -0.0849523 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0689188 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | -0.0670491 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0588431 |
| 120 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0536983 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | -0.0507243 |
| 122 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0420692 |
| 123 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0416773 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0232745 |
| 125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0174360 |

